Abstract The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative
(KDOQI) has provided evidence-based guidelines for hemodialysis vascular access since …

Vascular access remains one of the most challenging aspects of renal replacement therapy.
If the vascular access does not function properly, then haemodialysis will not remove …

Background End‐stage renal disease (ESRD) patients often require either the formation of
an arteriovenous (AV) fistula or an AV interposition prosthetic shunt for haemodialysis …

The objective of this study was to assess whether vitamin D (VD) treatment alters the overall
all-cause and cardiovascular mortalities in a chronic kidney disease (CKD) population. We …

Chronic kidney disease affects 40% of adults aged 65 and older. Anemia of CKD is present
in 30% of patients with CKD and is associated with increased cardiovascular risk, decreased …

BACKGROUND: Arteriovenous fistulae (AVF) are the preferred vascular access for
hemodialysis in patients with end-stage kidney disease. Chronic kidney disease (CKD) is …

Clinical failure of arteriovenous neointimal hyperplasia (NIH) fistulae (AVF) is frequently due
to juxta-anastomotic NIH (JANIH). Although the mouse AVF model recapitulates human AVF …

Vitamin D has been shown to have multiple pleiotropic effects beyond bone and mineral
metabolism, with purported roles in cardiovascular disease, cancer, and host immunity …

Background Few therapies prevent venous neointimal hyperplasia (VNH) and venous
stenosis (VS) formation in arteriovenous fistulas (AVF). Expression of the immediate early …

Background People with end‐stage renal disease (ESRD) often require either the formation
of an arteriovenous fistula (AVF) or an interposition prosthetic arteriovenous graft (AVG) for …